Mulroy Michael H. 4
4 · BIOTIME INC · Filed Mar 15, 2019
Insider Transaction Report
Form 4
BIOTIME INCBTX
Mulroy Michael H.
Director
Transactions
- Award
Common Shares, no par value
2019-03-08+194,271→ 226,821 total
Footnotes (1)
- [F1]Acquired pursuant to that certain Agreement and Plan of Merger, dated November 7, 2018 (the "Merger Agreement"), by and between the Issuer, Patrick Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, and Asterias Biotherapeutics, Inc., a Delaware corporation ("Asterias"). Pursuant to the Merger Agreement, each share of Series A common stock of Asterias was converted into the right to receive 0.71 common shares of the Issuer.